Skip to main content

Find Clinical Trials

Home
Conditions
Coronary Restenosis

Clinical trial condition

Coronary Restenosis

Explore clinical trials studying Coronary Restenosis. Study availability and eligibility vary by location and protocol.

85 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Coronary Restenosis trial results

Completed

PCI vs. CABG in UPLM-ISR

NCT04968977

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +10 more
Locations: Fabrizio D'Ascenzo Turin, Italy

Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital Bialystok, Poland

First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland Gdansk, Poland

Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland Katowice, Poland

View Trial Details

Completed

Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions

NCT02229864

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +8 more
Locations: Scottsdale Healthcare Scottsdale, Arizona, United States

Cardiac & Vascular Research Center of Northern Michigan Petoskey, Michigan, United States

View Trial Details

Completed

SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents

NCT00714545

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations: Scripps Green Hospital/Scripps Clinic La Jolla, California, United States

View Trial Details

Completed

Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)

NCT00963781

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +10 more
Locations: Scripps Clinic La Jolla, California, United States

View Trial Details

Completed

AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population

NCT01844284

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations: Nagoya Daini Red Cross Hospital Nagoya, Aichi-ken, Japan

Fujita Health University Toyoake-shi, Aichi-ken, Japan

ShinTokyo Matsudo-shi, Chiba, Japan

Kokura Memorial Hospital Kitakyushu-shi, Fukuoka, Japan

View all 39 locations

View Trial Details

Completed

XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study

NCT01894152

Conditions: Angioplasty, Arterial Occlusive Diseases, Arteriosclerosis, +18 more
Locations: Abbott Vascular Santa Clara, California, United States

View Trial Details

Completed

EXCEL Clinical Trial

NCT01205776

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
Locations: Abbott Vascular Santa Clara, California, United States

View Trial Details

Completed

Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)

NCT02151812

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +9 more
Locations: Centre Hospitalier Saint Joseph Saint Luc de Lyon Lyon, France

Clinique du Millénaire, Montpellier Montpellier, France

CHU Montpellier, Hôpital Arnaud de Villeneuve Montpellier, France

CHU de Nantes, Hopital Laennec Nantes, France

View Trial Details

Completed

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)

NCT01923740

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +8 more
Locations: Abbott Vascular Santa Clara, California, United States

View Trial Details

Completed

ABSORB II Randomized Controlled Trial

NCT01425281

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations: Abbott Vascular International BVBA Brussels, Belgium

View Trial Details